Skip to main content
. 2024 Mar 21;19:132. doi: 10.1186/s13023-024-03101-4

Table 3.

Clinical characteristics in the two groups

TO (n = 78) non-TO (n = 116) P value
Age (year) 14.0 ± 3.9 14.9 ± 3.2 0.111
Menarche 0.044
 Post-menarche 60(76.9%) 103(88.8%)
 Pre-menarche 18(23.1%) 13( (11.2%)
Onset of pain 0.000
 Acute onset 69(88.5%) 45(38.8%)
 Non-acute onset 9(11.5%) 71(61.2%)
Duration of pain 0.000
 ≤3 months 76(97.4%) 87(75.0%)
 >3 months 2(2.6%) 29(25.0%)
Outcome of pain 0.000
 Persistent or recurrence 72(92.3%) 47(40.5%)
 Spontaneous remission 6(7.7%) 69(59.5%)
Complain of nausea and vomiting 0.000
 No 39(50.0%) 89(76.6%)
 Yes 39(50.0%) 27(23.3%)
Fever 0.413
 Yes 2(2.6%) 5(4.3%)
 No 76(97.4%) 111(95.7)
Location 0.000
 Right or left quadrant 54(69.2%) 49(42.2%)
 Not accurate site and/or referred pain 24(30.8%) 67(57.8%)
Ultrasound 0.527
 Cystic 70(87.5%) 104(89.7%)
 Solid 8(2.1%) 12(1.7%)
Surgical approach 0.000
 Cystectomy 52(66.7%) 105(90.5%)
 Oophorectomy and/or salpingectomy 26(33.3%) 11(9.5%)
Tumor size 8.8 ± 3.4 8.7 ± 5.0 0.884
Tumor size(Median) 0.038
 <5 cm 9(11.5%) 29(25.0%)
 ≥5 cm 69(88.5%) 87(75.0%)
Laterality 0.434
 Left 33(42.3%) 49(42.2%)
 Right 43(55.1%) 58(50.0%)
 Bilateral 2(2.6%) 9(7.8%)